English Korean Chinese
ホーム > 市場調査レポート > 医療機器 > 心血管装置 > 世界の末梢血管装置の競合動向：2008年
カテゴリ
医療機器 (4760)
CT/MRI/X線 (172)
eヘルス (329)
カテーテル (240)
ディスポーザブル (77)
画像診断 (417)
核医学 (80)
眼科機器 (102)
歯科機器 (176)
心血管装置 (339)
整形外科 (341)
生体計測 (391)
創傷ケア (163)
体外診断装置 (557)
超音波 (55)
内視鏡 (160)
分子イメージング/造影剤 (28)
市場調査レポート

世界の末梢血管装置の競合動向：2008年

Global Competitor Insights for Peripheral Vascular Disease 2008

発行 Millennium Research Group
出版日 2008年06月 商品コード 73368
ページ情報 英文  
価格
US$ 4,197 換算 ¥ 337,732 (税抜) Web Access and PDF Download (Single user license)
US$ 6,300 換算 ¥ 506,961 (税抜) Web Access and PDF Download (Corporate use license)


原文目次

Abstract

MRG' s Global Competitor Insights for Peripheral Vascular Devices 2008 report covers the US, Europe (France, Germany, Italy, and the UK), and Japan, and includes PV stents, percutaneous transluminal angioplasty (PTA) balloon catheters, embolic protection devices (EPDs), inferior vena cava filters (IVCFs), aortic stent grafts, and PV accessory devices.

Millennium Research Group' s (MRG) Global Competitor Insights for Peripheral Vascular Devices 2008 report provides an in depth analysis of each of the top nine competitors in the global peripheral vascular (PV) device market. This report serves as a tool for evaluating each company' s performance relative to its competitors.

Table of Contents

EXECUTIVE SUMMARY

METHODOLOGY

1.0 GLOBAL PERIPHERAL VASCULAR DEVICE MARKET

  • 1.1 Market Overview
    • 1.1.1 Procedures
    • 1.1.2 Peripheral Vascular Devices
    • 1.1.2.1 Peripheral Vascular Stents
    • 1.1.2.2 Percutaneous Transluminal Angioplasty Balloon Catheters
    • 1.1.2.3 Embolic Protection Devices
    • 1.1.2.4 Inferior Vena Cava Filters
    • 1.1.2.5 Aortic Stent Grafts
    • 1.1.2.6 Peripheral Vascular Accessory Devices
  • 1.2 Regional Analysis
    • 1.2.1 Global Analysis
    • 1.2.2 US Analysis
    • 1.2.3 Europe Analysis
    • 1.2.4 Japan Analysis

2.0 CORDIS (JOHNSON & JOHNSON)

  • 2.1 Company Overview
    • 2.1.1 Recent Events
    • 2.1.2 Company Analysis
    • 2.1.3 S.W.O.T. Analysis
    • 2.1.3.1 Strengths
    • 2.1.3.2 Weaknesses
    • 2.1.3.3 Opportunities
    • 2.1.3.4 Threats
  • 2.2 Peripheral Vascular Device Profile
    • 2.2.1 Peripheral Vascular Stent Summary
    • 2.2.2 PTA Balloon Catheter Summary
    • 2.2.3 Embolic Protection Device Summary
    • 2.2.4 Inferior Vena Cava Filter Summary
    • 2.2.5 Peripheral Vascular Accessory Device Summary

3.0 BOSTON SCIENTIFIC

  • 3.1 Company Overview
    • 3.1.1 Recent Events
    • 3.1.2 Company Analysis
    • 3.1.3 S.W.O.T. Analysis
    • 3.1.3.1 Strengths
    • 3.1.3.2 Weaknesses
    • 3.1.3.3 Opportunities
    • 3.1.3.4 Threats
  • 3.2 Peripheral Vascular Device Profile
    • 3.2.1 Peripheral Vascular Stent Summary
    • 3.2.2 PTA Balloon Catheter Summary
    • 3.2.3 Embolic Protection Device Summary
    • 3.2.4 Inferior Vena Cava Filter Summary
    • 3.2.5 Peripheral Vascular Accessory Device Summary

4.0 W.L. GORE

  • 4.1 Company Overview
    • 4.1.1 Recent Events
    • 4.1.2 Company Analysis
    • 4.1.3 S.W.O.T. Analysis
    • 4.1.3.1 Strengths
    • 4.1.3.2 Weaknesses
    • 4.1.3.3 Opportunities
    • 4.1.3.4 Threats
  • 4.2 Peripheral Vascular Device Profile
    • 4.2.1 Peripheral Vascular Stent Device Summary
    • 4.2.2 Embolic Protection Device Summary
    • 4.2.3 Aortic Stent Graft Summary

5.0 COOK MEDICAL

  • 5.1 Company Overview
    • 5.1.1 Recent Events
    • 5.1.2 Company Analysis
    • 5.1.3 S.W.O.T. Analysis
    • 5.1.3.1 Strengths
    • 5.1.3.2 Weaknesses
    • 5.1.3.3 Opportunities
    • 5.1.3.4 Threats
  • 5.2 Peripheral Vascular Device Profile
    • 5.2.1 Peripheral Vascular Stent Summary
    • 5.2.2 PTA Balloon Catheter Summary
    • 5.2.3 Inferior Vena Cava Filter Summary
    • 5.2.4 Aortic Stent Graft Summary
    • 5.2.5 Peripheral Vascular Accessory Device Summary

6.0 ABBOTT VASCULAR

  • 6.1 Company Overview
    • 6.1.1 Recent Events
    • 6.1.2 Company Analysis
    • 6.1.3 S.W.O.T. Analysis
    • 6.1.3.1 Strengths
    • 6.1.3.2 Weaknesses
    • 6.1.3.3 Opportunities
    • 6.1.3.4 Threats
  • 6.2 Peripheral Vascular Device Profile
    • 6.2.1 Peripheral Vascular Stent Device Summary
    • 6.2.2 PTA Balloon Catheter Summary
    • 6.2.3 Embolic Protection Device Summary
    • 6.2.4 Peripheral Vascular Accessory Device Summary

7.0 C. R. BARD

  • 7.1 Company Overview
    • 7.1.1 Recent Events
    • 7.1.2 Company Analysis
    • 7.1.3 S.W.O.T. Analysis
    • 7.1.3.1 Strengths
    • 7.1.3.2 Weaknesses
    • 7.1.3.3 Opportunities
    • 7.1.3.4 Threats
    • 7.2 Peripheral Vascular Device Profile
    • 7.2.1 Peripheral Vascular Stent Summary
    • 7.2.2 PTA Balloon Catheter Summary
    • 7.2.3 Inferior Vena Cava Filter Summary

8.0 MEDTRONIC

  • 8.1 Company Overview
    • 8.1.1 Recent Events
    • 8.1.2 Company Analysis
    • 8.1.3 S.W.O.T. Analysis
    • 8.1.3.1 Strengths
    • 8.1.3.2 Weaknesses
    • 8.1.3.3 Opportunities
    • 8.1.3.4 Threats
  • 8.2 Peripheral Vascular Device Profile
    • 8.2.1 Peripheral Vascular Stent Summary
    • 8.2.2 Embolic Protection Device Summary
    • 8.2.3 Aortic Stent Graft Summary

9.0 TERUMO MEDICAL

  • 9.1 Company Overview
    • 9.1.1 Recent Events
    • 9.1.2 Company Analysis
    • 9.1.3 S.W.O.T. Analysis
    • 9.1.3.1 Strengths
    • 9.1.3.2 Weaknesses
    • 9.1.3.3 Opportunities
    • 9.1.3.4 Threats
  • 9.2 Peripheral Vascular Device Profile
    • 9.2.1 Aortic Stent Graft Device Summary
    • 9.2.2 Peripheral Vascular Accessory Device Summary

10.0 EV3

  • 10.1 Company Overview
    • 10.1.1 Recent Events
    • 10.1.2 Company Analysis
    • 10.1.3 S.W.O.T. Analysis
    • 10.1.3.1 Strengths
    • 10.1.3.2 Weaknesses
    • 10.1.3.3 Opportunities
    • 10.1.3.4 Threats
  • 10.2 Peripheral Vascular Device Profile
    • 10.2.1 Peripheral Vascular Stent Summary
    • 10.2.2 PTA Balloon Catheter Summary
    • 10.2.3 Embolic Protection Device Summary
    • 10.2.4 Peripheral Vascular Accessory Device Summary

APPENDIX A: MRG ACRONYMS AND INITIALISMS

Back to Top